MedTrace Logo

Comparison of Two DCCV Algorithms - Rational Versus Maximum Fixed Energy

NCT05148923 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-08-02

No results posted yet for this study

Summary

Direct current cardioversion (DCCV) is a widespread method to restore sinus rhythm in patients with atrial fibrillation. It is a safe and effective method of treating atrial fibrillation. In this study, the investigators want to compare two algorithms. The rational one, with lower initial energy and the second one with the maximum possible shock energy.

Conditions

Interventions

PROCEDURE

Direct current cardioversion (DCCV)

DCCV is a safe and effective method of treating atrial fibrillation.

Sponsors & Collaborators

  • Nemocnice AGEL Trinec-Podlesi a.s.

    lead OTHER

Principal Investigators

  • Lucjan Rucki, MD · Nemocnice AGEL Trinec-Podlesi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05148923 on ClinicalTrials.gov